STRS Ohio’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $795K | Buy |
18,400
+6,600
| +56% | +$285K | ﹤0.01% | 1008 |
|
|
2025
Q1 | $408K | Buy |
11,800
+4,400
| +59% | +$152K | ﹤0.01% | 1287 |
|
|
2024
Q4 | $203K | Buy |
7,400
+500
| +7% | +$13.7K | ﹤0.01% | 1504 |
|
|
2024
Q3 | $176K | Hold |
6,900
| – | – | ﹤0.01% | 1592 |
|
|
2024
Q2 | $175K | Buy |
6,900
+2,200
| +47% | +$55.7K | ﹤0.01% | 1594 |
|
|
2024
Q1 | $145K | Sell |
4,700
-4,300
| -48% | -$133K | ﹤0.01% | 1625 |
|
|
2023
Q4 | $363K | Buy |
9,000
+2,100
| +30% | +$84.7K | ﹤0.01% | 1406 |
|
|
2023
Q3 | $181K | Buy |
+6,900
| New | +$181K | ﹤0.01% | 1588 |
|
|
2022
Q1 | – | Sell |
-7,300
| Closed | -$121K | – | 2145 |
|
|
2021
Q4 | $121K | Sell |
7,300
-3,600
| -33% | -$59.7K | ﹤0.01% | 1860 |
|
|
2021
Q3 | $510K | Sell |
10,900
-2,600
| -19% | -$122K | ﹤0.01% | 1500 |
|
|
2021
Q2 | $822K | Sell |
13,500
-800
| -6% | -$48.7K | ﹤0.01% | 1305 |
|
|
2021
Q1 | $880K | Buy |
14,300
+6,400
| +81% | +$394K | ﹤0.01% | 1244 |
|
|
2020
Q4 | $561K | Buy |
7,900
+2,600
| +49% | +$185K | ﹤0.01% | 1413 |
|
|
2020
Q3 | $198K | Buy |
5,300
+500
| +10% | +$18.7K | ﹤0.01% | 1672 |
|
|
2020
Q2 | $156K | Buy |
+4,800
| New | +$156K | ﹤0.01% | 1693 |
|
|
2020
Q1 | – | Sell |
-5,900
| Closed | -$206K | – | 2026 |
|
|
2019
Q4 | $206K | Hold |
5,900
| – | – | ﹤0.01% | 1668 |
|
|
2019
Q3 | $126K | Buy |
+5,900
| New | +$126K | ﹤0.01% | 1729 |
|